|
US20020150539A1
(en)
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
|
US7083572B2
(en)
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
|
US5958371A
(en)
*
|
1995-06-08 |
1999-09-28 |
Barnes-Jewish Hospital |
Site specific binding system, nuclear imaging compositions and methods
|
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
|
US6331289B1
(en)
|
1996-10-28 |
2001-12-18 |
Nycomed Imaging As |
Targeted diagnostic/therapeutic agents having more than one different vectors
|
|
US20070036722A1
(en)
*
|
1996-10-28 |
2007-02-15 |
Pal Rongved |
Separation processes
|
|
US6261537B1
(en)
|
1996-10-28 |
2001-07-17 |
Nycomed Imaging As |
Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
|
|
ES2257771T3
(es)
|
1996-10-28 |
2006-08-01 |
Amersham Health As |
Agentes de contraste.
|
|
EP0991427A2
(en)
*
|
1996-10-28 |
2000-04-12 |
Marsden, John Christopher |
Improvements in or relating to diagnostic/therapeutic agents
|
|
CA2270120A1
(en)
|
1996-10-28 |
1998-05-07 |
Pal Rongved |
Improvements in or relating to diagnostic/therapeutic agents
|
|
EP0973552B1
(en)
*
|
1996-10-28 |
2006-03-01 |
Amersham Health AS |
Improvements in or relating to diagnostic/therapeutic agents
|
|
BR9713978A
(pt)
*
|
1996-10-28 |
2000-05-02 |
Nycomed Imaging As |
Agente diagnóstico alvejável e/ou terapeuticamente ativo, processo para preparação e uso do mesmo, formulação combinada, e, processos para gerar imagens intensificadas de um corpo animal humano ou não-humano e para investigação in vitro de alvejamento por um agente
|
|
EP0963209A2
(en)
*
|
1996-10-28 |
1999-12-15 |
Marsden, John Christopher |
Improvements in or relating to diagnostic/therapeutic agents
|
|
DE19709704C2
(de)
*
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
|
AU7104598A
(en)
*
|
1997-04-09 |
1998-10-30 |
Philipp Lang |
New technique to monitor drug delivery noninvasively (in vivo)
|
|
US7452551B1
(en)
|
2000-10-30 |
2008-11-18 |
Imarx Therapeutics, Inc. |
Targeted compositions for diagnostic and therapeutic use
|
|
US6416740B1
(en)
*
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
|
JP2003521475A
(ja)
*
|
1999-05-25 |
2003-07-15 |
バーンズ−ジューウィッシュ・ホスピタル |
部位特異的結合系、核画像化組成物及び方法
|
|
AU762944B2
(en)
*
|
1999-06-23 |
2003-07-10 |
Cornell Research Foundation Inc. |
Dehydration/rehydration of marked liposomes on a test device
|
|
WO2001005433A2
(en)
*
|
1999-07-14 |
2001-01-25 |
Board Of Regents, The University Of Texas System |
Delivery and retention of activity agents to lymph nodes
|
|
US7220401B2
(en)
*
|
1999-09-24 |
2007-05-22 |
Barnes-Jewish Hospital |
Blood clot-targeted nanoparticles
|
|
US6576460B1
(en)
|
1999-10-28 |
2003-06-10 |
Cornell Research Foundation, Inc. |
Filtration-detection device and method of use
|
|
US20020103165A1
(en)
*
|
2000-02-29 |
2002-08-01 |
Alliance Pharmaceutical Corp., |
Engineered spray-dried lipid-based microparticles for cellular targeting
|
|
US6676963B1
(en)
*
|
2000-10-27 |
2004-01-13 |
Barnes-Jewish Hospital |
Ligand-targeted emulsions carrying bioactive agents
|
|
US7179449B2
(en)
*
|
2001-01-30 |
2007-02-20 |
Barnes-Jewish Hospital |
Enhanced ultrasound detection with temperature-dependent contrast agents
|
|
US7279150B2
(en)
*
|
2002-01-24 |
2007-10-09 |
Barnes-Jewish Hospital |
Chelating agents with lipophilic carriers
|
|
KR100978126B1
(ko)
|
2002-01-24 |
2010-08-26 |
반즈 쥬이쉬 하스피털 |
인테그린 표적화 조영제
|
|
CA2478822C
(en)
|
2002-03-11 |
2016-07-12 |
Passport Technologies, Inc. |
Transdermal drug delivery patch system, method of making same and method of using same
|
|
US6869591B2
(en)
*
|
2002-03-26 |
2005-03-22 |
Barnes-Jewish Hospital |
Paramagnetic particles that provide improved relaxivity
|
|
DE60318435T2
(de)
|
2002-05-31 |
2008-12-24 |
Cornell Research Foundation, Inc. |
Universeller biosensor und verfahren zur verwendung
|
|
JP2007521254A
(ja)
*
|
2003-06-25 |
2007-08-02 |
ゲルベ |
診断画像用化合物
|
|
WO2005014051A1
(en)
*
|
2003-08-08 |
2005-02-17 |
Barnes-Jewish Hospital |
Emulsion particles for imaging and therapy and methods of use thereof
|
|
JP2007511616A
(ja)
*
|
2003-11-19 |
2007-05-10 |
バーンズ−ジューイッシュ ホスピタル |
増強された薬物送達
|
|
WO2005077407A1
(en)
*
|
2004-01-16 |
2005-08-25 |
Barnes-Jewish Hospital |
Targeted atherosclerosis treatment
|
|
EP1713513B1
(en)
|
2004-01-16 |
2014-06-04 |
Carnegie Mellon University |
Cellular labeling for nuclear magnetic resonance techniques
|
|
EP1768558A4
(en)
|
2004-06-09 |
2009-11-25 |
Kereos Inc |
LIPOPHILES DERIVATIVES OF CHELATE MONOAMIDES
|
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
|
WO2006096499A2
(en)
*
|
2005-03-04 |
2006-09-14 |
Washington University |
Mr coronary angiography with a fluorinated nanoparticle contrast agent at 1.5 t
|
|
EP1716870A1
(en)
*
|
2005-04-29 |
2006-11-02 |
Bracco Imaging S.p.A. |
MRI contrast agents endowed with concentration independent responsiveness
|
|
US20070048383A1
(en)
*
|
2005-08-25 |
2007-03-01 |
Helmus Michael N |
Self-assembled endovascular structures
|
|
US20070232909A1
(en)
*
|
2006-03-28 |
2007-10-04 |
Washington University |
Ultrasonic Characterization of Internal Body Conditions Using Information Theoretic Signal Receivers
|
|
EP2010646A2
(en)
|
2006-04-14 |
2009-01-07 |
Carnegie Mellon University |
Cellular labeling and quantification for nuclear magnetic resonance techniques
|
|
US9308198B2
(en)
|
2006-09-08 |
2016-04-12 |
Rhode Island Hospital |
Treatment, prevention, and reversal of alcohol-induced brain disease
|
|
ES2399147T3
(es)
|
2006-09-08 |
2013-03-26 |
Rhode Island Hospital |
Tratamiento, prevención y reversión de una enfermedad hepática alcohólica
|
|
EP1938801A1
(en)
|
2006-12-22 |
2008-07-02 |
Biofrontera Bioscience GmbH |
Nanoemulsion
|
|
JP2008162981A
(ja)
*
|
2006-12-28 |
2008-07-17 |
Japan Science & Technology Agency |
ビオチン化ないしホーミングペプチド提示型バイオナノカプセル
|
|
US7646198B2
(en)
*
|
2007-03-09 |
2010-01-12 |
Case Western Reserve University |
Methods for fat signal suppression in magnetic resonance imaging
|
|
FR2914303A1
(fr)
|
2007-03-28 |
2008-10-03 |
Guerbet Sa |
Composes pour le diagnostic de l'apoptose.
|
|
FR2914304B1
(fr)
|
2007-03-28 |
2012-11-16 |
Guerbet Sa |
Composes pour le diagnostic de maladies liees a l'expression de vcam.
|
|
JP5645658B2
(ja)
|
2007-07-10 |
2014-12-24 |
カーネギー メロン ユニバーシティー |
核磁気共鳴技術のための細胞標識を製造するための組成物及び方法
|
|
EP2209420A4
(en)
|
2007-10-09 |
2014-01-22 |
Univ St Louis |
PARTICULARS FOR IMAGING
|
|
US9468607B2
(en)
|
2007-10-09 |
2016-10-18 |
Washington University |
Ligand directed toroidal nanoparticles for therapy and diagnostic imaging
|
|
EP2112366B1
(en)
|
2008-04-23 |
2011-11-02 |
Magneti Marelli S.p.A. |
Electromagnetic fuel injector for gaseous fuels with anti-wear stop device
|
|
WO2009155335A2
(en)
*
|
2008-06-19 |
2009-12-23 |
University Of Maryland, Baltimore |
Conjugates of 19f mr imaging tracers and chemotherapeutic agents for drug quantification and drug dose individualization
|
|
US9808500B2
(en)
|
2009-12-17 |
2017-11-07 |
Washington University |
Antithrombotic nanoparticle
|
|
JP2013514999A
(ja)
|
2009-12-17 |
2013-05-02 |
ワシントン・ユニバーシティ |
抗血栓性ナノ粒子
|
|
AU2011239414A1
(en)
|
2010-04-15 |
2012-11-08 |
The Washington University |
Prodrug compositions, prodrug nanoparticles, and methods of use thereof
|
|
WO2012159107A1
(en)
|
2011-05-19 |
2012-11-22 |
Rhode Island Hospital |
Inhibition of renal fibrosis
|
|
WO2013116691A1
(en)
|
2012-02-02 |
2013-08-08 |
The Washington University |
Methods for improving muscle strength
|
|
WO2013158265A1
(en)
|
2012-04-20 |
2013-10-24 |
Genelux Corporation |
Imaging methods for oncolytic virus therapy
|
|
WO2015099094A1
(ja)
|
2013-12-27 |
2015-07-02 |
国立大学法人東京医科歯科大学 |
アルツハイマー病及び前頭側頭葉変性症の診断方法、診断薬、治療薬、及びこれら薬剤のスクリーニング方法
|
|
US10213448B2
(en)
|
2016-03-25 |
2019-02-26 |
Novazoi Theranostics |
Ethanolamine-based lipid biosynthetic compounds, method of making and use thereof
|
|
US10987315B1
(en)
|
2018-12-04 |
2021-04-27 |
University Of South Florida |
Antithrombotic nanoparticles and methods for treating necrotizing enterocolitis
|
|
JP7196581B2
(ja)
*
|
2018-12-10 |
2022-12-27 |
大同特殊鋼株式会社 |
被検査材の組織検査方法
|
|
WO2024208433A1
(en)
|
2023-04-06 |
2024-10-10 |
Biofrontera Bioscience Gmbh |
Nanoemulsion without propylene glycol
|
|
WO2024208434A1
(en)
|
2023-04-06 |
2024-10-10 |
Biofrontera Bioscience Gmbh |
Pressurized nanoemulsion
|